HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bilateral idiopathic granulomatous mastitis.

AbstractOBJECTIVES:
Idiopathic granulomatous mastitis (IGM) is a benign rare inflammatory pseudotumor. Bilateral involvement of IGM has been reported in a few cases. To our knowledge, this study is the largest series of bilateral cases to date. The goals of this study were to present clinical features of bilateral IGM and to evaluate the results of treatments.
MATERIALS AND METHODS:
We performed a retrospective review of the idiopathic granulomatous mastitis database from 2010 to 2013. Ten female patients who met required histologic and clinical criteria of IGM in both breasts were included in study. Demographic data, clinical findings, medication history, and radiologic findings are presented.
RESULTS:
The mean age at onset of the disease was 38.4 ± 8.3 years (range: 29-52 years). Nine patients had no recurrence during a mean follow-up period of 21 months (range: 11-26 months). Additionally, the median time to second breast involvement was 15.6 months.
CONCLUSION:
Bilateral IGMs have a higher rate of more relapse and greater resistance to medical therapies than do unilateral IGMs. Surgical management should be avoided unless all medical treatment options have been exhausted. Nevertheless, expectant management seems a rational option for the treatment of bilateral IGM.
AuthorsMehmet Velidedeoglu, Fahrettin Kilic, Birgul Mete, Mucahit Yemisen, Varol Celik, Ertugrul Gazioglu, Mehmet Ferahman, Resat Ozaras, Mehmet Halit Yilmaz, Fatih Aydogan
JournalAsian journal of surgery (Asian J Surg) Vol. 39 Issue 1 Pg. 12-20 (Jan 2016) ISSN: 0219-3108 [Electronic] Netherlands
PMID25944108 (Publication Type: Journal Article)
CopyrightCopyright © 2015. Published by Elsevier Taiwan.
Topics
  • Adult
  • Female
  • Granulomatous Mastitis (diagnostic imaging, pathology, therapy)
  • Humans
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: